These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7967727

  • 21. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 22. All trans retinoic acid and cancer.
    Siddikuzzaman, Guruvayoorappan C, Berlin Grace VM.
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):241-9. PubMed ID: 20929432
    [Abstract] [Full Text] [Related]

  • 23. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK, Tucker C, Favours E, Cheshire PJ, Creech J, Billups CA, Smykla R, Lee FY, Houghton PJ.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Chen GQ, Shen ZX, Wu F, Han JY, Miao JM, Zhong HJ, Li XS, Zhao JQ, Zhu J, Fang ZW, Chen SJ, Chen Z, Wang ZY.
    Leukemia; 1996 May 01; 10(5):825-8. PubMed ID: 8656678
    [Abstract] [Full Text] [Related]

  • 25. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 26. Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo.
    Armstrong JL, Taylor GA, Thomas HD, Boddy AV, Redfern CP, Veal GJ.
    Br J Cancer; 2007 Jun 04; 96(11):1675-83. PubMed ID: 17486130
    [Abstract] [Full Text] [Related]

  • 27. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B, Takimoto CH, Goetz A, Diab S, Hammond LA, Smetzer L, Schwartz G, Gazak R, Callaghan JT, Von Hoff DD, Rowinsky EK.
    Clin Cancer Res; 2003 Nov 15; 9(15):5540-9. PubMed ID: 14654534
    [Abstract] [Full Text] [Related]

  • 28. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 29. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
    Ponthan F, Kogner P, Bjellerup P, Klevenvall L, Hassan M.
    Br J Cancer; 2001 Dec 14; 85(12):2004-9. PubMed ID: 11747346
    [Abstract] [Full Text] [Related]

  • 30. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G, Brandmaier P, Scholz G, Ackermann OP, Alt R, Rothe K, Cross M, Witzigmann H, Tröbs RB.
    J Pediatr Surg; 2008 Jul 14; 43(7):1284-94. PubMed ID: 18639684
    [Abstract] [Full Text] [Related]

  • 31. Retinoid therapy of high-risk neuroblastoma.
    Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ.
    Cancer Lett; 2003 Jul 18; 197(1-2):185-92. PubMed ID: 12880980
    [Abstract] [Full Text] [Related]

  • 32. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles.
    Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I.
    J Control Release; 2005 Mar 21; 103(2):369-80. PubMed ID: 15763620
    [Abstract] [Full Text] [Related]

  • 33. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR, Liu PY, Alberts DS, Peng YM, Fisher E, Xu MJ, Scudder SA, Baker LH, Moore DF, Lippman SM.
    Gynecol Oncol; 1998 Dec 21; 71(3):386-90. PubMed ID: 9887236
    [Abstract] [Full Text] [Related]

  • 34. Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.
    Wadler S, Schwartz EL, Anderson P, Runowicz CD, Chuang L, Del Priore G, Hochster H, Goldberg G, Fields A, Loewen G, Haynes H.
    Cancer J Sci Am; 1999 Dec 21; 5(3):165-70. PubMed ID: 10367173
    [Abstract] [Full Text] [Related]

  • 35. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T.
    Acta Haematol Pol; 1995 Dec 21; 26(3):269-77. PubMed ID: 8525772
    [Abstract] [Full Text] [Related]

  • 36. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
    Di Francesco AM, Meco D, Torella AR, Barone G, D'Incalci M, Pisano C, Carminati P, Riccardi R.
    Biochem Pharmacol; 2007 Mar 01; 73(5):643-55. PubMed ID: 17150196
    [Abstract] [Full Text] [Related]

  • 37. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov 01; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 38. Clinical pharmacology of all-trans retinoic acid.
    Muindi JR, Young CW, Warrell RP.
    Leukemia; 1994 Nov 01; 8(11):1807-12. PubMed ID: 7967726
    [Abstract] [Full Text] [Related]

  • 39. Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model.
    Choi Y, Kim SY, Park K, Yang J, Cho KJ, Kwon HJ, Byun Y.
    Int J Pharm; 2006 Aug 31; 320(1-2):45-52. PubMed ID: 16730144
    [Abstract] [Full Text] [Related]

  • 40. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
    Ganser A, Seipelt G, Verbeek W, Ottmann OG, Maurer A, Kolbe K, Hess U, Elsner S, Reutzel R, Wörmann B.
    Leukemia; 1994 Mar 31; 8(3):369-75. PubMed ID: 7510354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.